Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blood substitutes.

R M Winslow1

  • 1Sangart, Inc., San Diego, CA 92121, USA.

Advanced Drug Delivery Reviews
|June 6, 2000
PubMed
Summary
This summary is machine-generated.

Red cell substitutes, designed to temporarily replace transfused blood, are nearing the market. These oxygen carriers promise to alleviate blood shortages and improve medical access globally.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Forward Modeling of Coronal Mass Ejection Flux Ropes in the Inner Heliosphere with 3DCORE.

Space weather : the international journal of research & applications·2018
Same author

Factors Affecting the Geo-effectiveness of Shocks and Sheaths at 1 AU.

Journal of geophysical research. Space physics·2018
Same author

Modeling observations of solar coronal mass ejections with heliospheric imagers verified with the Heliophysics System Observatory.

Space weather : the international journal of research & applications·2017
Same author

CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats.

British journal of pharmacology·2008
Same author

A randomized, single-blind, increasing dose safety trial of an oxygen-carrying plasma expander (Hemospan) administered to orthopaedic surgery patients with spinal anaesthesia.

Transfusion medicine (Oxford, England)·2008
Same author

Current status of oxygen carriers ('blood substitutes'): 2006.

Vox sanguinis·2006
Same journal

Silicone oil in protein drug products and its implications for formulation stability.

Advanced drug delivery reviews·2026
Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026
Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026
Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026
See all related articles

Area of Science:

  • Biomedical Engineering
  • Hematology
  • Medical Devices

Background:

  • Red cell substitutes are artificial oxygen carriers developed to address limitations of traditional blood transfusions.
  • The development of these substitutes has faced challenges due to the complexity of oxygen transport within the body.

Purpose of the Study:

  • To review the current status and future potential of red cell substitutes.
  • To highlight the impact of red cell substitute research on understanding oxygen delivery to tissues.

Main Methods:

  • Review of existing research and clinical trial data on red cell substitutes.
  • Analysis of the advantages and limitations of various red cell substitute products.

Main Results:

Related Experiment Videos

  • Several red cell substitute products are in advanced clinical trials and approaching market availability.
  • The development process, though slow, has yielded significant insights into oxygen delivery mechanisms.

    • Conclusions:

    • Red cell substitutes are poised to alleviate global blood shortages and expand healthcare access.
    • Further development is expected to accelerate, leading to improved oxygen carrier technologies and a deeper understanding of tissue oxygenation.